Q1FY25 results: Zydus Lifesciences net profit rises 31% to Rs 1,420 cr
Company receives USFDA approval for Valbenazine Capsules Revenue from operations at Rs. 62,075 mn, up 21% YoY Research & Development ...
Tag: Valbenazine Capsules
